Structural and Energetic Characteristics of the Heparin-binding Site in Antithrombotic Protein C*

Human activated protein C (APC) is a key component of a natural anticoagulant system that regulates blood coagulation. In vivo, the catalytic activity of APC is regulated by two serpins, α1-antitrypsin and the protein C inhibitor (PCI), the inhibition by the latter being stimulated by heparin. We have identified a heparin-binding site in the serine protease domain of APC and characterized the energetic basis of the interaction with heparin. According to the counter-ion condensation theory, the binding of heparin to APC is 66% ionic in nature and comprises four to six net ionic interactions. To localize the heparin-binding site, five recombinant APC variants containing amino acid exchanges in loops 37, 60, and 70 (chymotrypsinogen numbering) were created. As demonstrated by surface plasmon resonance, reduction of the electropositive character of loops 37 and 60 resulted in complete loss of heparin binding. The functional consequence was loss in heparin-induced stimulation of APC inhibition by PCI, whereas the PCI-induced APC inhibition in the absence of heparin was enhanced. Presumably, the former observations were due to the inability of heparin to bridge some APC mutants to PCI, whereas the increased inhibition of certain APC variants by PCI in the absence of heparin was due to reduced repulsion between the enzymes and the serpin. The heparin-binding site of APC was also shown to interact with heparan sulfate, albeit with lower affinity. In conclusion, we have characterized and spatially localized the functionally important heparin/heparan sulfate-binding site of APC.

[1]  M. Murakami,et al.  c-Kit Ligand Mediates Increased Expression of Cytosolic Phospholipase A, Prostaglandin Endoperoxide Synthase-1, and Hematopoietic Prostaglandin D Synthase and Increased IgE-dependent Prostaglandin D Generation in Immature Mouse Mast Cells (*) , 1995, The Journal of Biological Chemistry.

[2]  M. Pantoliano,et al.  Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.

[3]  J. Griffin,et al.  Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen , 1994, Protein science : a publication of the Protein Society.

[4]  J. Rosing,et al.  Coagulation Factor V: An Old Star Shines Again , 1997, Thrombosis and Haemostasis.

[5]  B. Dahlbäck,et al.  Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[7]  W. Cleland,et al.  The statistical analysis of enzyme kinetic data. , 1967, Advances in enzymology and related areas of molecular biology.

[8]  K. Mann,et al.  The mechanism of inactivation of human factor V and human factor Va by activated protein C. , 1994, The Journal of biological chemistry.

[9]  J. Sheehan,et al.  Molecular mapping of the heparin-binding exosite of thrombin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Deléage,et al.  Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR. , 1999, Biochemistry.

[11]  L. L. Neese,et al.  Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor. , 1998, Archives of biochemistry and biophysics.

[12]  B. Dahlbäck,et al.  Involvement of Lys 62[217] and Lys 63[218] of Human Anticoagulant Protein C in Heparin Stimulation of Inhibition by the Protein C Inhibitor , 1999, Thrombosis and Haemostasis.

[13]  G. Pfleiderer.  [34] Particle-bound aminopeptidase from pig kidney , 1970 .

[14]  B. Furie,et al.  The molecular basis of blood coagulation , 1988, Cell.

[15]  B. Faller,et al.  Heparin-induced conformational change and activation of mucus proteinase inhibitor. , 1992, Biochemistry.

[16]  J. Griffin,et al.  Physiologic inhibition of human activated protein C by alpha 1-antitrypsin. , 1988, The Journal of biological chemistry.

[17]  A. Wacey,et al.  A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency , 1993, British journal of haematology.

[18]  S Foundling,et al.  The 2.8 A crystal structure of Gla‐domainless activated protein C. , 1996, The EMBO journal.

[19]  F. España,et al.  Heparin Stimulation of the Inhibition of Activated Protein C and other Enzymes by Human Protein C Inhibitor - Influence of the Molecular Weight of Heparin and Ionic Strength , 1996, Thrombosis and Haemostasis.

[20]  S. Stone,et al.  Interaction of activated protein C with serpins. , 1993, The Biochemical journal.

[21]  C. Esmon,et al.  The Protein C Pathway: New Insights , 1997, Thrombosis and Haemostasis.

[22]  A. Sali,et al.  Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood , 1996, The Journal of experimental medicine.

[23]  S. Olson,et al.  Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. , 1991, The Journal of biological chemistry.

[24]  W. Chuang,et al.  Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin. , 2000, Biochemistry.

[25]  T. Lohman,et al.  Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity , 1978, Quarterly Reviews of Biophysics.

[26]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[27]  Richard L. Stevens,et al.  Packaging of Proteases and Proteoglycans in the Granules of Mast Cells and Other Hematopoietic Cells , 1995, The Journal of Biological Chemistry.

[28]  P. Wingfield,et al.  Identification and dynamics of a heparin-binding site in hepatocyte growth factor. , 1999, Biochemistry.

[29]  M Karplus,et al.  Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes. , 1993, The Journal of biological chemistry.

[30]  K. Preissner,et al.  Calcium-Dependent Activation of Protein C by Thrombin/Thrombomudulin: Role of Negatively Charged Amino Acids within the Activation Peptide of Protein C , 1994, Thrombosis and Haemostasis.

[31]  G. S. Manning.  The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides , 1978, Quarterly Reviews of Biophysics.

[32]  B. Dahlbäck,et al.  Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin. , 2000, Biochemistry.

[33]  S. Olson,et al.  Regulation of Thrombin Activity by Antithrombin and Heparin , 1994, Seminars in thrombosis and hemostasis.

[34]  Y. Zuo,et al.  Identification of the Antithrombin III Heparin Binding Site* , 1997, The Journal of Biological Chemistry.

[35]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.